Page results
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
The pancreatobiliary department at UCLH is one of few centres in the UK to provide a patient-centred, comprehensive advanced interventional endoscopy service for diseases of the pancreas and biliary tree.
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
-
Information about the integrated cancer care service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
-
Concerned about the impact of climate change on people with neurological conditions, Professor Sanjay Sisodiya has established established a consortium of neurological specialists and will be undertaking research.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
This page provides information about anaesthesia for children having proton beam therapy.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
File results
-
FOI/2024/0607 - Starvation ketoacidosis patients/ treatment
-
FOI/2024/0605 - Finance software system/ installation and expiry of software
-
FOI/2024/0597 - Urothelial cancer treatments
-
FOI/2024/0595 - Capital estate activity for 2020-2024
-
FOI/2024/0594 - Implementation of Federated Data Platform (FDP) and procurement of data platforms
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2022/0780 - Hereditary Angioedema (HAE) service
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments